"HIV" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Descriptor ID |
D006678
|
| MeSH Number(s) |
B04.820.650.589.650.350
|
| Concept/Terms |
HIV- HIV
- Human Immunodeficiency Virus
- Immunodeficiency Virus, Human
- Immunodeficiency Viruses, Human
- Virus, Human Immunodeficiency
- Viruses, Human Immunodeficiency
- Human Immunodeficiency Viruses
- Human T Cell Lymphotropic Virus Type III
- Human T-Cell Lymphotropic Virus Type III
- Human T-Cell Leukemia Virus Type III
- Human T Cell Leukemia Virus Type III
- LAV-HTLV-III
- Lymphadenopathy-Associated Virus
- Lymphadenopathy Associated Virus
- Lymphadenopathy-Associated Viruses
- Virus, Lymphadenopathy-Associated
- Viruses, Lymphadenopathy-Associated
- Human T Lymphotropic Virus Type III
- Human T-Lymphotropic Virus Type III
- AIDS Virus
- AIDS Viruses
- Virus, AIDS
- Viruses, AIDS
- Acquired Immune Deficiency Syndrome Virus
- Acquired Immunodeficiency Syndrome Virus
- HTLV-III
|
Below are MeSH descriptors whose meaning is more general than "HIV".
Below are MeSH descriptors whose meaning is more specific than "HIV".
This graph shows the total number of publications written about "HIV" by people in this website by year, and whether "HIV" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 3 | 3 |
| 1995 | 3 | 0 | 3 |
| 1997 | 2 | 1 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 4 | 5 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 5 | 5 |
| 2003 | 8 | 5 | 13 |
| 2004 | 2 | 2 | 4 |
| 2005 | 3 | 0 | 3 |
| 2007 | 1 | 2 | 3 |
| 2008 | 4 | 5 | 9 |
| 2009 | 1 | 1 | 2 |
| 2010 | 3 | 2 | 5 |
| 2011 | 5 | 4 | 9 |
| 2012 | 4 | 3 | 7 |
| 2013 | 2 | 1 | 3 |
| 2014 | 3 | 3 | 6 |
| 2015 | 2 | 2 | 4 |
| 2016 | 3 | 1 | 4 |
| 2017 | 2 | 1 | 3 |
| 2018 | 4 | 6 | 10 |
| 2019 | 0 | 5 | 5 |
| 2020 | 4 | 7 | 11 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 5 | 5 |
| 2023 | 2 | 2 | 4 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV" by people in Profiles.
-
Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (Anal Precancer) Among Women With Human Immunodeficiency Virus. Clin Infect Dis. 2024 03 20; 78(3):681-689.
-
Adaptation of Chagas Disease Screening Recommendations for a Community of At-risk HIV in the United States. Clin Infect Dis. 2024 02 17; 78(2):453-456.
-
Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program. Viruses. 2023 Dec 23; 16(1).
-
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087). Clin Cancer Res. 2023 12 15; 29(24):5038-5046.
-
Brief Report: Challenges in Obtaining the Informed Perspectives of Stakeholders Regarding HIV Molecular Epidemiology. J Acquir Immune Defic Syndr. 2023 06 01; 93(2):87-91.
-
Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. Clin Infect Dis. 2023 02 18; 76(4):592-599.
-
Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis. Clin Infect Dis. 2023 01 06; 76(1):10-17.
-
Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency Virus Status. Obstet Gynecol. 2023 01 01; 141(1):135-143.
-
Screening for Chagas Disease Should Be Included in Entry-to-Care Testing for At-Risk People With Human Immunodeficiency Virus (HIV) Living in the United States. Clin Infect Dis. 2022 09 14; 75(5):901-906.
-
Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children. Clin Infect Dis. 2022 08 25; 75(2):347-355.